Figure 1
Schematic representation of human tenascin-C, pTn28 and A–D recombinant fragments and strategy to generate a BC4-like antibody.
Figure 1 | British Journal of Cancer
Schematic representation of human tenascin-C, pTn28 and A–D recombinant fragments and strategy to generate a BC4-like antibody.
